Yes, that frivolous lawsuit (and potentially more) is exactly what I was referring to. This one may just be a small-time player looking to get paid or maybe they’re testing the waters to see the response. It’s an old trick right out of the playbook often used against tiny biotechs that possess potentially game-changing technology that threatens the preferred status quo of the powerful. This reincorporation move actually says a lot. BTW - We all know it’s bogus, and nothing will come of the lawsuit. There was no corporate misconduct or fraud, and no false or misleading statements were made.
Obviously, coming from Bellicum, Peter knows the Houston area and it makes a lot of sense that the new Marker Therapeutics should be headquartered there, not only for the partnership with BCM, but also to access the talented pool of workers that will be needed to grow the business. Everyone thinks of Kendall Square and the Bay Area as the hottest biotech areas of the country, but actually Houston is up and coming.
News 
Market Data 
Discover 
AI
